Literature DB >> 14626625

High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis.

K Suzuki1, T Sawada, A Murakami, T Matsui, S Tohma, K Nakazono, M Takemura, Y Takasaki, T Mimori, K Yamamoto.   

Abstract

OBJECTIVE: We investigated the rheumatoid arthritis (RA) diagnostic performances of anti-cyclic citrullinated peptide antibody (anti-CCP) and antifilaggrin antibody (AFA) in comparison with RF and matrix metalloproteinase-3 (MMP-3).
METHODS: We used a second generation enzyme-linked immunosorbent assay (ELISA) kit for the detection of anti-CCP. We constructed recombinant human filaggrin, which was citrullinated in vitro by human peptidylarginine deiminase, and subsequently used it as the coating antigen for AFA-ELISA. A total of 549 RA patients and 208 other rheumatic disease patients were included in the study.
RESULTS: The specificities of anti-CCP (88.9%) and AFA (94.7%) were superior to those of RF (81.7%) and MMP-3 (49.5%). The sensitivity of anti-CCP (87.6%) was superior to all others. However, the sensitivity of AFA (68.7%) was inferior to those of RF (69.8%) and MMP-3 (75.7%). Furthermore, receiver operating characteristic curves of anti-CCP and AFA passed closer to the upper left corner than those of RF and MMP-3, and the areas under the curves (AUC) of AFA and anti-CCP were significantly larger. In addition, the AUC of anti-CCP was significantly larger than that of AFA.
CONCLUSION: ELISA detection of antibodies to citrullinated antigens, especially a second generation anti-CCP, showed higher discriminative ability than other assays, including RF, and would be useful to aid the diagnosis of RA in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14626625     DOI: 10.1080/03009740310003677

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  42 in total

1.  Second generation automated anti-CCP test better predicts the clinical diagnosis of rheumatoid arthritis.

Authors:  Mohamed Elrefaei; Kristie Boose; Martha McGee; Teresa K Tarrant; Feng-Chang Lin; Jason P Fine; John L Schmitz
Journal:  J Clin Immunol       Date:  2011-11-10       Impact factor: 8.317

2.  Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis.

Authors:  Toshihiro Matsui; Kota Shimada; Shigeto Tohma
Journal:  Clin Rheumatol       Date:  2005-11-10       Impact factor: 2.980

3.  Leg pains, clubbing of digits and lung mass: what is your call?

Authors:  Jenn-Yu Wu; Jin-Yuan Shih
Journal:  CMAJ       Date:  2008-02-12       Impact factor: 8.262

Review 4.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

5.  Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis.

Authors:  F Jouen; O Vittecoq; F Leguillou; I Tabti-Titon; J F Menard; O Mejjad; S Pouplin; P Boumier; P Fardellone; A Gayet; D Gilbert; F Tron; X Le Loët
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

6.  The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.

Authors:  Ct Chou; Ht Liao; Ch Chen; Ws Chen; Hp Wang; Ky Su
Journal:  Biomark Insights       Date:  2007-05-03

7.  Autoimmunity to citrullinated type II collagen in rheumatoid arthritis.

Authors:  Mamoru Yoshida; Michiko Tsuji; Daitaro Kurosaka; Daisaburo Kurosaka; Jun Yasuda; Yoshitaka Ito; Tetsuro Nishizawa; Akio Yamada
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

8.  Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis.

Authors:  Koichiro Ohmura; Chikashi Terao; Etsuko Maruya; Masaki Katayama; Kenichiro Matoba; Kota Shimada; Akira Murasawa; Shigeru Honjo; Kiyoshi Takasugi; Shigeto Tohma; Keitaro Matsuo; Kazuo Tajima; Naoichiro Yukawa; Daisuke Kawabata; Takaki Nojima; Takao Fujii; Ryo Yamada; Hiroo Saji; Fumihiko Matsuda; Tsuneyo Mimori
Journal:  Rheumatology (Oxford)       Date:  2010-09-09       Impact factor: 7.580

Review 9.  Update on autoantibodies in rheumatoid arthritis.

Authors:  S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

Review 10.  Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies.

Authors:  Y W Song; E H Kang
Journal:  QJM       Date:  2009-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.